Low and asymmetrical hippocampal glutamate levels in healthy older adults. (20th December 2022)
- Record Type:
- Journal Article
- Title:
- Low and asymmetrical hippocampal glutamate levels in healthy older adults. (20th December 2022)
- Main Title:
- Low and asymmetrical hippocampal glutamate levels in healthy older adults
- Authors:
- Roalf, David R
Robinson, Heather
Kesselring, Irena
Jee, Joelle
Mordy, Arianna
Ruparel, Kosha
Meeks, Jacqueline
Wolk, David A.
Nanga, Ravi Prakash Reddy
Gur, Ruben C
Reddy, Ravinder - Abstract:
- Abstract: Background: Glutamate (Glu) is a critical molecule in cellular metabolism and the most abundant excitatory neurotransmitter in the brain. Glutamate dysfunction is common in neurodegenerative disorders—patients with Alzheimer's disease (AD) have lower hippocampal glutamate—and likely contributes to age‐related declines in cognitive functioning. The extant literature on age‐related changes in brain Glu is small and all studies have employed proton spectroscopy. Thus, in this investigation we use a novel 7T magnetic resonanace imaging technique, Glutamate Chemical Exchange Saturation Transfer (GluCEST), to compare bilateral hippocampal brain Glu in between healthy old and young adults. Method: Hippocampal GluCEST data were acquired from 14 healthy older adults [HOA; age: 71 (+/‐3)] and 10 young healthy adults [HYA; age: 21 (+/‐3)] using a Siemens 7T Terra. GluCEST data was acquired in axial slice positioned through bilateral hippocampus. Associations between MoCA scores and bilateral hippocampal GluCEST levels were investigated. Result: Bilateral glutamate levels were 7% higher HYA as compared to HOA. HOA showed significant asymmetry (Left>Right) within the hippocampus while GluCEST in HYA were equivalent across hemisphere (t(22)=2.37, p<0.03). Within HOA, higher left hippocampal GluCEST levels were associated with higher performance on the MoCA [r(13)=0.55, p<0.04]. Conclusion: GluCEST appears to be a marker of aging‐related neurological and cognitive change. TheAbstract: Background: Glutamate (Glu) is a critical molecule in cellular metabolism and the most abundant excitatory neurotransmitter in the brain. Glutamate dysfunction is common in neurodegenerative disorders—patients with Alzheimer's disease (AD) have lower hippocampal glutamate—and likely contributes to age‐related declines in cognitive functioning. The extant literature on age‐related changes in brain Glu is small and all studies have employed proton spectroscopy. Thus, in this investigation we use a novel 7T magnetic resonanace imaging technique, Glutamate Chemical Exchange Saturation Transfer (GluCEST), to compare bilateral hippocampal brain Glu in between healthy old and young adults. Method: Hippocampal GluCEST data were acquired from 14 healthy older adults [HOA; age: 71 (+/‐3)] and 10 young healthy adults [HYA; age: 21 (+/‐3)] using a Siemens 7T Terra. GluCEST data was acquired in axial slice positioned through bilateral hippocampus. Associations between MoCA scores and bilateral hippocampal GluCEST levels were investigated. Result: Bilateral glutamate levels were 7% higher HYA as compared to HOA. HOA showed significant asymmetry (Left>Right) within the hippocampus while GluCEST in HYA were equivalent across hemisphere (t(22)=2.37, p<0.03). Within HOA, higher left hippocampal GluCEST levels were associated with higher performance on the MoCA [r(13)=0.55, p<0.04]. Conclusion: GluCEST appears to be a marker of aging‐related neurological and cognitive change. The present findings are similar to previous findings in AD (Graff‐Radford et al., 2013) Moreover, the left‐right asymmetry in GluCEST aligns with recent translational studies indicating a left‐right dissociation in long‐term memory function, which may be partially mediated by asymmetries in glutamate receptor content (Shipton et al., 2014). This preliminary study is the first to compare GluCEST levels in young and older adults and is the first step towards elucidate age‐related trajectories of glutamatergic alterations and their relationship to clinical and cognitive phenotypes. … (more)
- Is Part Of:
- Alzheimer's & dementia. Volume 18(2022)Supplement 1
- Journal:
- Alzheimer's & dementia
- Issue:
- Volume 18(2022)Supplement 1
- Issue Display:
- Volume 18, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 18
- Issue:
- 1
- Issue Sort Value:
- 2022-0018-0001-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-12-20
- Subjects:
- Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/alz.065278 ↗
- Languages:
- English
- ISSNs:
- 1552-5260
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24759.xml